Availability: In Stock

Generic Pharmacuetical Patent and FDA Law, 2024-2025 ed.

SKU: WEST.GNL.3769.01052

$1,010.00

Publisher: Thomson Reuters
Number of Pages: 1546
ISBN-13: 9781731923769
Condition: New

50 in stock

Category: Brands:

Description

Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration (FDA) approval of generic drugs and the interaction of patents and FDA law. A practitioners guide, it walks the reader through the stages of drug approval, identifying the critical issues in the process and advising the client about the issues and areas of concern or exploitation. It also discusses the areas that impact the interaction of patents and Food and Drug Administration law, including litigation. Features of this publication include: Provides a step-by-step process for understanding, strategizing, and litigating generic drug patent infringement Provides comprehensive background in patent and (FDA) regulatory law, integrating them into one cohesive bundle Dissects each complex issue into its parts and cross-references it to other issues Provides an excellent teaching tool for associates, partners, law clerks, judges, and financial managers Provides case studies, illustrations, and timelines Covers the generic drug industry exclusively, blending generic drug patent, and FDA issues Offers citations to cases.

Additional information

Book Author

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.